Insider · CIK 0001532617
EPPSTEIN DEBORAH ANNE
Reports to the SEC for 1 company · SALT LAKE CITY, UT
Transactions
14
Companies
1
Filings
5
CIK
0001532617
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2015-09-09 | Q Therapeutics, Inc.Option to Purchase Common StockA Award | +$10.8K |
| 2014-12-18 | Q Therapeutics, Inc.Option to Purchase Common StockA Award | +$210K |
| 2014-12-18 | Q Therapeutics, Inc.Option to Purchase Common StockA Award | +$200K |
| 2014-03-11 | Q Therapeutics, Inc.Option to Purchase Common StockA Award | +$175K |
| 2014-03-11 | Q Therapeutics, Inc.Option to Purchase Common StockA Award | +$193K |
| 2014-03-11 | Q Therapeutics, Inc.Option to Purchase Common StockA Award | +$94.9K |
| 2012-03-28 | Q Therapeutics, Inc.Options to Purchase Common StockA Award | +$250K |
| 2011-10-13 | Q Therapeutics, Inc.A Award | — |
| 2011-10-13 | Q Therapeutics, Inc.Options to Purchase Common StockA Award | — |
| 2011-10-13 | Q Therapeutics, Inc.Options to Purchase Common StockA Award | — |
| 2011-10-13 | Q Therapeutics, Inc.Options to Purchase Common StockA Award | — |
| 2011-10-13 | Q Therapeutics, Inc.Options to Purchase Common StockA Award | — |
| 2011-10-13 | Q Therapeutics, Inc.Options to Purchase Common StockA Award | — |
| 2011-10-13 | Q Therapeutics, Inc.Options to Purchase Common StockA Award | — |
Recent filings
- 5Q Therapeutics, Inc.0001209191-16-098217SEC(opens sec.gov)
- 4Q Therapeutics, Inc.0001209191-14-077313SEC(opens sec.gov)
- 4Q Therapeutics, Inc.0001209191-14-020504SEC(opens sec.gov)
- 5Q Therapeutics, Inc.0001209191-13-040378SEC(opens sec.gov)
- 5EPPSTEIN DEBORAH ANNE0001387131-12-001029SEC(opens sec.gov)
Companies
Address
Q THERAPEUTICS, INC 615 ARAPEEN DR, SUITE 102
SALT LAKE CITY, UT, 84108